Duke Team Reaches Milestone with Portable Cervical Cancer Screening Device

February 14, 2017

Since 2012, Nimmi Ramanujam, professor of biomedical engineering and global health and director of the Center for Global Women’s Health Technologies and her research team have been developing and testing a portable colposcope, called the “Pocket Colposcope,” to increase access to cervical cancer screening in primary care settings. Last month, 20 of these devices were produced for distribution to international partners.


Duke-Margolis Center for Health Policy Launches in Washington, DC

February 14, 2017

Last Thursday, February 9, the Duke-Margolis Center for Health Policy held a public launch event at the Newseum in Washington, DC. The mission of the center is to improve health and the value of health care by developing and implementing evidence-based policy solutions locally, nationally and globally.


Student Club Encourages Socially Responsible University Licensing

February 07, 2017

Nearly half of all people in low and middle income countries don’t have affordable access to medicines that could save their life. This statistic is one of the driving forces behind the work that Universities Allied for Essential Medicines (UAEM) does around the world.


DGHI Welcomes Six New Faculty Affiliates

February 07, 2017

In the past year, the Duke Global Health Institute (DGHI) has welcomed six new affiliate faculty members representing a wide range of academic disciplines, including engineering, obstetrics and gynecology, romance studies, pulmonary care, pediatrics and environmental science. Meet the new affiliates.


DGHI Research Roundup: January 2017

February 07, 2017

Eighteen DGHI-affiliated authors—including faculty, staff and alumni—recently shared new discoveries on a variety of global health topics in peer-reviewed publications. 


DGHI Affiliate Contributes to Development of WHO Dengue Guidelines

January 31, 2017

In summer 2016, the World Health Organization (WHO) issued guidelines on the implementation of Dengvaxia, the first vaccine against all four dengue serotypes, or strains. Katia Koelle, associate professor of biology and Duke Global Health Institute (DGHI) affiliate, was among a consortium of researchers selected to generate model-based predictions of the long-term safety, health and economic impact of the vaccine.